A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Practolol
Boldenone
The risk or severity of edema formation can be increased when Boldenone is combined with Fluticasone furoate.
Practolol
Androstenedione
The risk or severity of edema formation can be increased when Androstenedione is combined with Fluticasone furoate.
Practolol
Androstenediol
The risk or severity of edema formation can be increased when Androstenediol is combined with Fluticasone furoate.
Practolol
Clostebol
The risk or severity of edema formation can be increased when Clostebol is combined with Fluticasone furoate.
Practolol
4-Hydroxytestosterone
The risk or severity of edema formation can be increased when 4-Hydroxytestosterone is combined with Fluticasone furoate.
Practolol
1-Testosterone
The risk or severity of edema formation can be increased when 1-Testosterone is combined with Fluticasone furoate.
Practolol
Bolasterone
The risk or severity of edema formation can be increased when Bolasterone is combined with Fluticasone furoate.
Practolol
5-androstenedione
The risk or severity of edema formation can be increased when 5-androstenedione is combined with Fluticasone furoate.
Practolol
19-norandrostenedione
The risk or severity of edema formation can be increased when 19-norandrostenedione is combined with Fluticasone furoate.
Practolol
Phenylacetic acid
The therapeutic efficacy of Phenylacetic acid can be decreased when used in combination with Fluticasone furoate.
Practolol
Glycerol phenylbutyrate
The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Fluticasone furoate.
Practolol
Phenylbutyric acid
The therapeutic efficacy of Phenylbutyric acid can be decreased when used in combination with Fluticasone furoate.
Practolol
Alcuronium
The risk or severity of myopathy and weakness can be increased when Alcuronium is combined with Fluticasone furoate.
Practolol
Gallamine
The risk or severity of myopathy and weakness can be increased when Gallamine is combined with Fluticasone furoate.
Practolol
Atracurium
The risk or severity of myopathy and weakness can be increased when Atracurium is combined with Fluticasone furoate.
Practolol
Neosaxitoxin
The risk or severity of myopathy and weakness can be increased when Neosaxitoxin is combined with Fluticasone furoate.
Practolol
Pyrantel
The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Fluticasone furoate.
Practolol
Rapacuronium
The risk or severity of myopathy and weakness can be increased when Rapacuronium is combined with Fluticasone furoate.
Practolol
Metocurine
The risk or severity of myopathy and weakness can be increased when Metocurine is combined with Fluticasone furoate.
Practolol
Neostigmine
The therapeutic efficacy of Neostigmine can be decreased when used in combination with Fluticasone furoate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3